Predictive models and applicability of artificial intelligence-based approaches in drug allergy.

Journal: Current opinion in allergy and clinical immunology
Published Date:

Abstract

PURPOSE OF REVIEW: Drug allergy is responsible for a huge burden on public healthcare systems, representing in some instances a threat for patient's life. Diagnosis is complex due to the heterogeneity of clinical phenotypes and mechanisms involved, the limitations of in vitro tests, and the associated risk to in vivo tests. Predictive models, including those using recent advances in artificial intelligence, may circumvent these drawbacks, leading to an appropriate classification of patients and improving their management in clinical settings.

Authors

  • Rafael Núñez
    Allergy Research Group, Biomedical Research Institute of Malaga (IBIMA)-BIONAND Platform.
  • Inmaculada Doña
    Allergy Research Group, Biomedical Research Institute of Malaga (IBIMA)-BIONAND Platform.
  • José Antonio Cornejo-García
    Allergy Research Group, Biomedical Research Institute of Malaga (IBIMA)-BIONAND Platform.